Diabetes, Diabetes Mellitus, Type 2
Conditions
Brief summary
This study is conducted in Europe. The aim of this observational study is to gain practical experience with once-daily Levemir administration in type 2 diabetes patients who were previously treated with Insulatard®, Humulin® N (NPH insulins) as basal insulin as part of their ICT under normal clinical practice conditions in Hungary.
Interventions
DRUGinsulin detemir
observational study - dose and frequency to be prescribed by the physician as a result of standard clinical practice.
Sponsors
Novo Nordisk A/S
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Type 2 diabetic subjects on intensive insulin treatment (ICT) * Eligibility for once daily insulin detemir administration * Informed consent obtained before any observation-related activities
Exclusion criteria
* Known or suspected allergy to insulin detemir * Subjects previously enrolled in the observation * Women who are pregnant, breast feeding or have the intention of becoming pregnant within 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy (HbA1c) | 24 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Body weight | 24 weeks |
| Hypoglycaemia frequency | 24 weeks |
| FBG variability | 24 weeks |
| Insulin dose change | 24 weeks |
Countries
Hungary
Outcome results
None listed